Intelligent physical activity versus modified behavioral activation in adolescent and young adult cancer patients with psychological distress: A randomized, controlled pilot trial.
adolescent and young adult
behavioral activation
cancer patients
physical activity
psychological distress
salivary cortisol
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
revised:
28
06
2022
received:
22
04
2022
accepted:
29
06
2022
pubmed:
19
7
2022
medline:
1
2
2023
entrez:
18
7
2022
Statut:
ppublish
Résumé
More than 80% of adolescent and young adult cancer patients (AYACPs) experienced psychological distress. Physical activity and behavioral activation are effective to relieve the psychological distress in AYACPs. Participants aged 15-39 years diagnosed with malignant tumors were included. A total of 143 eligible AYACPs were randomly assigned to three groups. The treatment-as-usual group (N = 48) received routine care, the physical activity group (N = 47) received 8 weeks of physical activity program based on intelligent wearable devices, and the behavioral activation group (N = 48) received an internet-based modified behavioral activation program for 8 weeks. Objective outcome measures included salivary cortisol and testosterone. Linear mixed-model analyses showed significant differences between treatment-as-usual, physical activity and behavioral activation in salivary cortisol, as well as total scores on depression and anxiety, physical activity, self-efficacy, and social support. Significantly stronger effect sizes for physical activity group compared with behavioral activation group were found on physical activity (d = 0.53) (1 week after intervention), moderate activity (d = 0.61), and walking activity (d = 0.57) (3-month follow-up). Intelligent, wearable, device-based physical activity program is more effective in alleviating anxiety and depression, reducing saliva cortisol, and improving physical activity in AYACPs than internet-based modified behavioral activation program. Intelligent, wearable, device-based physical activity program can reduce the time cost of AYACPs to ensure that the intervention is carried out.
Sections du résumé
BACKGROUND
More than 80% of adolescent and young adult cancer patients (AYACPs) experienced psychological distress. Physical activity and behavioral activation are effective to relieve the psychological distress in AYACPs.
METHODS
Participants aged 15-39 years diagnosed with malignant tumors were included. A total of 143 eligible AYACPs were randomly assigned to three groups. The treatment-as-usual group (N = 48) received routine care, the physical activity group (N = 47) received 8 weeks of physical activity program based on intelligent wearable devices, and the behavioral activation group (N = 48) received an internet-based modified behavioral activation program for 8 weeks. Objective outcome measures included salivary cortisol and testosterone.
RESULTS
Linear mixed-model analyses showed significant differences between treatment-as-usual, physical activity and behavioral activation in salivary cortisol, as well as total scores on depression and anxiety, physical activity, self-efficacy, and social support. Significantly stronger effect sizes for physical activity group compared with behavioral activation group were found on physical activity (d = 0.53) (1 week after intervention), moderate activity (d = 0.61), and walking activity (d = 0.57) (3-month follow-up).
CONCLUSIONS
Intelligent, wearable, device-based physical activity program is more effective in alleviating anxiety and depression, reducing saliva cortisol, and improving physical activity in AYACPs than internet-based modified behavioral activation program. Intelligent, wearable, device-based physical activity program can reduce the time cost of AYACPs to ensure that the intervention is carried out.
Identifiants
pubmed: 35848716
doi: 10.1002/cam4.5030
pmc: PMC9883549
doi:
Substances chimiques
Hydrocortisone
WI4X0X7BPJ
Types de publication
Randomized Controlled Trial
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1935-1948Informations de copyright
© 2022 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Cancer Nurs. 2017 May/Jun;40(3):217-223
pubmed: 27271366
Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
Clin J Oncol Nurs. 2016 Dec 1;20(6):630-634
pubmed: 27857256
Zhonghua Liu Xing Bing Xue Za Zhi. 2004 Mar;25(3):265-8
pubmed: 15200945
Health Psychol. 2000 Jan;19(1):12-20
pubmed: 10711583
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Andrologia. 2018 Feb;50(1):
pubmed: 28266735
J Am Acad Nurse Pract. 2011 Mar;23(3):135-42
pubmed: 21355946
Clin J Pain. 2012 May;28(4):291-9
pubmed: 21904196
Psychother Res. 2019 Apr;29(3):372-382
pubmed: 28838290
Psychooncology. 2018 Jul;27(7):1802-1809
pubmed: 29644783
Am J Physiol Regul Integr Comp Physiol. 2005 Nov;289(5):R1360-71
pubmed: 16221981
Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Jun 18;48(3):424-8
pubmed: 27318902
Med Sci Sports Exerc. 2010 Jul;42(7):1409-26
pubmed: 20559064
Neuroendocrinology. 2014;100(2-3):153-61
pubmed: 25228297
Ann Behav Med. 2010 Aug;40(1):89-98
pubmed: 20652466
Cancer. 2012 Oct 1;118(19):4884-91
pubmed: 22688896
Eur J Cancer Care (Engl). 2019 Jul;28(4):e13045
pubmed: 30993778
Psychooncology. 2014 Mar;23(3):241-50
pubmed: 25160838
Med J Aust. 2010 Jun 7;192(S11):S22-6
pubmed: 20528703
Cancer Nurs. 2015 Jul-Aug;38(4):312-21
pubmed: 25159078
Psychooncology. 2019 Oct;28(10):2083-2090
pubmed: 31397041
JMIR Cancer. 2016 May 24;2(1):e6
pubmed: 28410184
Mol Syst Biol. 2020 Jul;16(7):e9510
pubmed: 32672906
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Seishin Shinkeigaku Zasshi. 2015;117(1):42-8
pubmed: 26514045
Can J Psychiatry. 2016 Sep;61(9):576-87
pubmed: 27486153
Psychooncology. 2011 Mar;20(3):278-86
pubmed: 20238374
Eur J Appl Physiol. 2000 May;82(1-2):121-8
pubmed: 10879453
J Consult Clin Psychol. 2008 Dec;76(6):909-22
pubmed: 19045960
J Consult Clin Psychol. 2008 Jun;76(3):468-77
pubmed: 18540740
Psychoneuroendocrinology. 2009 Feb;34(2):163-171
pubmed: 19095358
Br J Med Psychol. 1988 Mar;61 ( Pt 1):17-36
pubmed: 3282536
Psychol Med. 2017 Aug;47(11):1990-2001
pubmed: 28374663
BMC Cancer. 2012 Aug 03;12:339
pubmed: 22862906
Clin J Oncol Nurs. 2017 Feb 1;21(1):123-126
pubmed: 28107331
Clin J Oncol Nurs. 2012 Jun 1;16(3):E84-98
pubmed: 22641333
J Thorac Dis. 2013 Jun;5 Suppl 1:S2-8
pubmed: 23819024
J Cancer Surviv. 2012 Sep;6(3):239-50
pubmed: 22457219
J Ment Health. 2019 Aug;28(4):410-418
pubmed: 29722574
Cancer Med. 2023 Jan;12(2):1935-1948
pubmed: 35848716
Physiol Behav. 2018 Mar 1;185:14-22
pubmed: 29248632
Clin Psychol Rev. 2015 Aug;40:57-65
pubmed: 26067572
Complement Ther Med. 2009 Jan;17(1):1-8
pubmed: 19114222
Support Care Cancer. 2016 Feb;24(2):539-546
pubmed: 26130364
Psychooncology. 2016 Nov;25(11):1308-1316
pubmed: 26403252
Cancer. 2017 Mar 1;123(5):869-878
pubmed: 27859009